1957 related articles for article (PubMed ID: 32612154)
1. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.
Zhang Y; Zhang Z
Cell Mol Immunol; 2020 Aug; 17(8):807-821. PubMed ID: 32612154
[TBL] [Abstract][Full Text] [Related]
2. Tissue-resident memory CD8
Wang T; Shen Y; Luyten S; Yang Y; Jiang X
Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
[TBL] [Abstract][Full Text] [Related]
3. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.
Liu Y; Guo J; Huang L
Theranostics; 2020; 10(7):3099-3117. PubMed ID: 32194857
[TBL] [Abstract][Full Text] [Related]
4. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
Saleh R; Elkord E
Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of gastric cancer: Past, future perspective and challenges.
Xie J; Fu L; Jin L
Pathol Res Pract; 2021 Feb; 218():153322. PubMed ID: 33422778
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
Take Y; Koizumi S; Nagahisa A
Front Immunol; 2020; 11():324. PubMed ID: 32210957
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapies: advances and bottlenecks.
Rui R; Zhou L; He S
Front Immunol; 2023; 14():1212476. PubMed ID: 37691932
[TBL] [Abstract][Full Text] [Related]
8. Tissue-resident memory-like T cells in tumor immunity: Clinical implications.
Dhodapkar MV; Dhodapkar KM
Semin Immunol; 2020 Jun; 49():101415. PubMed ID: 33011063
[TBL] [Abstract][Full Text] [Related]
9. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
Front Immunol; 2020; 11():784. PubMed ID: 32457745
[TBL] [Abstract][Full Text] [Related]
10. Unravelling the heterogeneity and dynamic relationships of tumor-infiltrating T cells by single-cell RNA sequencing analysis.
Yu X; Zhang L; Chaudhry A; Rapaport AS; Ouyang W
J Leukoc Biol; 2020 Jun; 107(6):917-932. PubMed ID: 32272497
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer.
Yuan X; Wang J; Huang Y; Shangguan D; Zhang P
Front Immunol; 2021; 12():643692. PubMed ID: 33717201
[TBL] [Abstract][Full Text] [Related]
13. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines.
Oladejo M; Paulishak W; Wood L
Semin Cancer Biol; 2023 Jan; 88():81-95. PubMed ID: 36526110
[TBL] [Abstract][Full Text] [Related]
14. Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome.
Araujo B de Lima V; Borch A; Hansen M; Draghi A; Spanggaard I; Rohrberg K; Reker Hadrup S; Lassen U; Svane IM
Cytotherapy; 2020 Apr; 22(4):204-213. PubMed ID: 32201034
[TBL] [Abstract][Full Text] [Related]
15. Tissue biomarkers of immune checkpoint inhibitor therapy.
Davoudi F; Moradi A; Sadeghirad H; Kulasinghe A
Immunol Cell Biol; 2024 Mar; 102(3):179-193. PubMed ID: 38228572
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy: accomplishments to date and future promise.
Helmy KY; Patel SA; Nahas GR; Rameshwar P
Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for esophageal cancer: a 2019 update.
Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
[TBL] [Abstract][Full Text] [Related]
18. Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches.
Klein K; He K; Younes AI; Barsoumian HB; Chen D; Ozgen T; Mosaffa S; Patel RR; Gu M; Novaes J; Narayanan A; Cortez MA; Welsh JW
Front Immunol; 2020; 11():573326. PubMed ID: 33178201
[TBL] [Abstract][Full Text] [Related]
19. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
Baxevanis CN; Fortis SP; Perez SA
Semin Cancer Biol; 2021 Jul; 72():76-89. PubMed ID: 31881337
[TBL] [Abstract][Full Text] [Related]
20. Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells.
Xie Y; Xie F; Zhang L; Zhou X; Huang J; Wang F; Jin J; Zhang L; Zeng L; Zhou F
Adv Sci (Weinh); 2021 Nov; 8(22):e2101672. PubMed ID: 34658167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
